Harvard Researchers Purchase HoloMonitor
Partners HealthCare International in Boston, Massachusetts, recently ordered its first and fully equipped HoloMonitor unit.
Partners HealthCare operates five Harvard Medical School-affiliated teaching hospitals. Unlike many medical schools, Harvard does not own or operate any hospitals. Instead, several hospitals are affiliated with Harvard to provide clinical training and research. With its teaching hospitals, Harvard Medical School is consistently ranked as the top medical school in the world.
Massachusetts General Hospital
“Partners HealthCare joins National Institutes of Health and UCSF as our most prestigious customers on the North American market. With HoloMonitor, it is possible to study cellular behavior in new ways, which innovative and cutting-edge researchers appreciate”, said Peter Egelberg, founder and CEO of PHI.
The ordered unit will be delivered and installed when the COVID-19 restrictions so permit.
Phase Holographic Imaging (PHI) leads the ground-breaking development of time-lapse cytometry instrumentation and software. With the first instrument introduced in 2011, the company today offers a range of products for long-term quantitative analysis of living cell dynamics that circumvent the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI trades through a network of international distributors. Committed to promoting the science and practice of time-lapse cytometry, PHI is actively expanding its customer base and scientific collaborations in cancer research, inflammatory and autoimmune diseases, stem cell biology, gene therapy, regenerative medicine and toxicological studies.